Effects of the early administration of Sivelestat (cas 127373-66-4) sodium on bronchopulmonary dysplasia in infants: A retrospective cohort study
-
Add time:08/08/2019 Source:sciencedirect.com
BackgroundChorioamnionitis, or infiltration of the chorioamnion by neutrophils, is a risk factor associated with the development of bronchopulmonary dysplasia. Increased neutrophil elastase levels are observed in the tracheal aspirates of these patients.
We also recommend Trading Suppliers and Manufacturers of Sivelestat (cas 127373-66-4). Pls Click Website Link as below: cas 127373-66-4 suppliers
Prev:Elevation of pivaloylcarnitine by Sivelestat (cas 127373-66-4) sodium in two children
Next:GAPDH/Siah1 cascade is involved in traumatic spinal cord injury and could be attenuated by Sivelestat (cas 127373-66-4) sodium) - 【Back】【Close 】【Print】【Add to favorite 】
-
Health and Chemical more >
-
Related Products


